Open source cancer database created for easier disease study

Researchers from the Johns Hopkins Kimmel Cancer Center and The Johns Hopkins University have created a novel database structure that allows investigators anywhere to more easily study multiple types ...
Le Lézard

Demeetra Publication in Biotechnology Progress Validates Integrated Platforms for Commercial Cell Line Development

Demeetra AgBio (Demeetra) today announced the publication of a peer-reviewed research article in Biotechnology Progress validating the performance of its integrated cell line development (CLD) ...

Promatix Biosciences Presents Positive Preclinical Data with First-in-Class PBS293 EGFR×EphA2 Cis-Bispecific ADC Demonstrating Enhanced Tumour Selectivity

Data presented at 16th World ADC London Summit with lead programme in colorectal cancer highlight the promise of Promatix’s proteomics-based ...

Primary Cells vs. Cell Lines: Cloud-Clone Corp. Empowers Researchers to Choose the Optimal Path for Discovery

The Trade-off Between Physiological Authenticity and Experimental Convenience: Navigating the Cellular Foundation of ...

Researchers repurpose existing lung cancer drug to fight ovarian tumors

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity decreases, scans show improvement, and patient lifespans are prolonged for some ...
The Barre-Montpelier Times Argus

Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models

Many TNBC tumors exhibit elevated intracellular iron levels and heightened oxidative stress, creating a biological reliance ...
Science Daily

Mysterious RNA led scientists to a hidden layer of cancer

A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across ...
FiercePharma

Merck pushes Keytruda across the FDA finish line for its first ovarian cancer nod

For all its success across a wide range of cancer types, Merck’s PD-1 superstar Keytruda has never been able to crack the code for one of the toughest-to-treat indications in oncology—ovarian cancer.
SciTech Daily

New Treatment Wipes Out Cancer Cells Without Harming Healthy Tissue

Researchers have developed a new cancer-targeting nanomaterial that exploits the unique chemistry inside tumors to trigger lethal oxidative stress while sparing healthy cells. Credit: Shutterstock A ...
IEEE

Cancer Cell Classification From Peripheral Blood Smear Data Using the YOLOv8 Architecture

Abstract: The accurate classification of cancer cells in the peripheral blood is essential for the diagnosis of leukemia and has traditionally been carried out by analyzing laboratory images. In this ...
Frontiers

Cell line bias in virus research: implications for viral propagation and biological interpretation

Cell lines are essential tools in virology for propagating viruses for characterization studies. However, reliance on a few historically popular lines—such as Vero, BHK-21, and MDCK—can introduce bias ...
Johns Hopkins Medicine

Johns Hopkins Scientists Develop Targeted Therapy for T-Cell Lymphomas and Leukemias

New from @hopkinskimmel: Researchers developed a TRBC2-targeting antibody–drug conjugate that selectively kills T-cell cancers while sparing healthy T cells in mice and lab models. The work expands a ...